Arjun Agarwal - 22 Jan 2025 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
SVP, Finance
Signature
/s/ Paul Quinlan, as attorney-in-fact for Arjun Agarwal
Issuer symbol
ORKA
Transactions as of
22 Jan 2025
Transactions value $
$0
Form type
4
Filing time
24 Jan 2025, 16:44:41 UTC
Previous filing
06 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORKA Employee Stock Option (right to buy) Award $0 +120K $0.00 120K 22 Jan 2025 Common Stock 120K $12.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.